Features, processing states, and heterologous protein interactions in the modulation of the retroviral nucleocapsid protein function

References

• Davis NL, Rueckert RR. Properties of a ribonucleoprotein particle isolated from Nonidet P-40-treated Rous sarcoma virus. J Virol 1972; 10:1010 - 1020
   PubMed Web of Science ®Google Scholar
• Davis J, Scherer M, Tsai WP, Long C. Low-molecular-weight Rauscher leukemia virus protein with preferential binding for single-stranded RNA and DNA. J Virol 1976; 18:709 - 718
   PubMed Web of Science ®Google Scholar
• Feng YX, Copeland TD, Henderson LE, Gorelick RJ, Bosche WJ, Levin JG, et al. HIV-1 nucleocapsid protein induces “maturation” of dimeric retroviral RNA in vitro. Proc Natl Acad Sci USA 1996; 93:7577 - 7581
   PubMed Web of Science ®Google Scholar
• Gorelick RJ, Henderson LE, Hanser JP, Rein A. Point mutants of Moloney murine leukemia virus that fail to package viral RNA: evidence for specific RNA recognition by a “zinc finger-like” protein sequence. Proc Natl Acad Sci USA 1988; 85:8420 - 8424
   PubMed Web of Science ®Google Scholar
• Meric C, Goff SP. Characterization of Moloney murine leukemia virus mutants with single-amino-acid substitutions in the Cys-His box of the nucleocapsid protein. J Virol 1989; 63:1558 - 1568
   PubMed Web of Science ®Google Scholar
• Meric C, Gouilloud E, Spahr PF. Mutations in Rous sarcoma virus nucleocapsid protein p12 (NC): deletions of Cys-His boxes. J Virol 1988; 62:3328 - 3333
   PubMed Web of Science ®Google Scholar
• Darlix JL, Gabus C, Nugeyre MT, Clavel F, Barre-Sinoussi F. Cis elements and trans-acting factors involved in the RNA dimerization of the human immunodeficiency virus HIV-1. J Mol Biol 1990; 216:689 - 699
   PubMed Web of Science ®Google Scholar
• Prats AC, Sarih L, Gabus C, Litvak S, Keith G, Darlix JL. Small finger protein of avian and murine retroviruses has nucleic acid annealing activity and positions the replication primer tRNA onto genomic RNA. EMBO J 1988; 7:1777 - 1783
   PubMed Web of Science ®Google Scholar
• Bampi C, Jacquenet S, Lener D, Decimo D, Darlix JL. The chaperoning and assistance roles of the HIV-1 nucleocapsid protein in proviral DNA synthesis and maintenance. Int J Biochem Cell Biol 2004; 36:1668 - 1686
   PubMed Web of Science ®Google Scholar
• Levin JG, Guo J, Rouzina I, Musier-Forsyth K. Nucleic acid chaperone activity of HIV-1 nucleocapsid protein: Critical role in reverse transcription and molecular mechanism. Progress in Nucleic Acids Res and Mol Biol 2005; 80:217 - 286
   PubMed Web of Science ®Google Scholar
• Rein A, Henderson LE, Levin JG. Nucleic-acid-chaperone activity of retroviral nucleocapsid proteins: significance for viral replication. Trends Biochem Sci 1998; 23:297 - 301
   PubMed Web of Science ®Google Scholar
• Thomas JA, Gorelick RJ. Nucleocapsid protein function in early infection processes. Virus Res 2008; 134:39 - 63
   PubMed Web of Science ®Google Scholar
• De Rocquigny H, Gabus C, Vincent A, Fournie-Zaluski MC, Roques B, Darlix JL. Viral RNA annealing activities of human immunodeficiency virus type 1 nucleocapsid protein require only peptide domains outside the zinc fingers. Proc Natl Acad Sci USA 1992; 89:6472 - 6476
   PubMed Web of Science ®Google Scholar
• Prats AC, Housset V, de Billy G, Cornille F, Prats H, Roques B, et al. Viral RNA annealing activities of the nucleocapsid protein of Moloney murine leukemia virus are zinc independent. Nucleic Acids Res 1991; 19:3533 - 3541
   PubMed Web of Science ®Google Scholar
• Amarasinghe GK, De Guzman RN, Turner RB, Chancellor KJ, Wu ZR, Summers MF. NMR structure of the HIV-1 nucleocapsid protein bound to stem-loop SL2 of the psi-RNA packaging signal. Implications for genome recognition. J Mol Biol 2000; 301:491 - 511
   PubMed Web of Science ®Google Scholar
• De Guzman RN, Wu ZR, Stalling CC, Pappalardo L, Borer PN, Summers MF. Structure of the HIV-1 nucleocapsid protein bound to the SL3 psi-RNA recognition element. Science 1998; 279:384 - 388
   PubMed Web of Science ®Google Scholar
• Cruceanu M, Urbaneja MA, Hixson CV, Johnson DG, Datta SA, Fivash MJ, et al. Nucleic acid binding and chaperone properties of HIV-1 Gag and nucleocapsid proteins. Nucleic Acids Res 2006; 34:593 - 605
   PubMed Web of Science ®Google Scholar
• Le Cam E, Coulaud D, Delain E, Petitjean P, Roques BP, Gerard D, et al. Properties and growth mechanism of the ordered aggregation of a model RNA by the HIV-1 nucleocapsid protein: an electron microscopy investigation. Biopolymers 1998; 45:217 - 229
   PubMed Web of Science ®Google Scholar
• Stewart-Maynard KM, Cruceanu M, Wang F, Vo MN, Gorelick RJ, Williams MC, et al. Retroviral nucleocapsid proteins display nonequivalent levels of nucleic acid chaperone activity. J Virol 2008; 82:10129 - 10142
   PubMed Web of Science ®Google Scholar
• Stoylov SP, Vuilleumier C, Stoylova E, De Rocquigny H, Roques BP, Gerard D, et al. Ordered aggregation of ribonucleic acids by the human immunodeficiency virus type 1 nucleocapsid protein. Biopolymers 1997; 41:301 - 312
   PubMed Web of Science ®Google Scholar
• Guo J, Wu T, Anderson J, Kane BF, Johnson DG, Gorelick RJ, et al. Zinc finger structures in the human immunodeficiency virus type 1 nucleocapsid protein facilitate efficient minus- and plus-strand transfer. J Virol 2000; 74:8980 - 8988
   PubMed Web of Science ®Google Scholar
• Peliska JA, Balasubramanian S, Giedroc DP, Benkovic SJ. Recombinant HIV-1 nucleocapsid protein accelerates HIV-1 reverse transcriptase catalyzed DNA strand transfer reactions and modulates RNase H activity. Biochemistry 1994; 33:13817 - 13823
   PubMed Web of Science ®Google Scholar
• You JC, McHenry CS. Human immunodeficiency virus nucleocapsid protein accelerates strand transfer of the terminally redundant sequences involved in reverse transcription. J Biol Chem 1994; 269:31491 - 1495
   PubMed Web of Science ®Google Scholar
• Dannull J, Surovoy A, Jung G, Moelling K. Specific binding of HIV-1 nucleocapsid protein to PSI RNA in vitro requires N-terminal zinc finger and flanking basic amino acid residues. EMBO J 1994; 13:1525 - 1533
   PubMed Web of Science ®Google Scholar
• Mori M, Dietrich U, Manetti F, Botta M. Molecular dynamics and DFT study on HIV-1 nucleocapsid protein-7 in complex with viral genome. J Chem Inf Model 2010; 50:638 - 650
   PubMed Web of Science ®Google Scholar
• Fisher RJ, Fivash MJ, Stephen AG, Hagan NA, Shenoy SR, Medaglia MV, et al. Complex interactions of HIV-1 nucleocapsid protein with oligonucleotides. Nucleic Acids Res 2006; 34:472 - 484
   PubMed Web of Science ®Google Scholar
• Demene H, Jullian N, Morellet N, de Rocquigny H, Cornille F, Maigret B, et al. Three-dimensional 1H NMR structure of the nucleocapsid protein NCp10 of Moloney murine leukemia virus. J Biomol NMR 1994; 4:153 - 170
   PubMed Web of Science ®Google Scholar
• Morellet N, de Rocquigny H, Mely Y, Jullian N, Demene H, Ottmann M, et al. Conformational behaviour of the active and inactive forms of the nucleocapsid NCp7 of HIV-1 studied by 1H NMR. J Mol Biol 1994; 235:287 - 301
   PubMed Web of Science ®Google Scholar
• Lee BM, De Guzman RN, Turner BG, Tjandra N, Summers MF. Dynamical behavior of the HIV-1 nucleocapsid protein. J Mol Biol 1998; 279:633 - 649
   PubMed Web of Science ®Google Scholar
• Berg JM. Potential metal-binding domains in nucleic acid binding proteins. Science 1986; 232:485 - 487
   PubMed Web of Science ®Google Scholar
• Covey SN. Amino acid sequence homology in gag region of reverse transcribing elements and the coat protein gene of cauliflower mosaic virus. Nucleic Acids Res 1986; 14:623 - 633
   PubMed Web of Science ®Google Scholar
• Morellet N, Jullian N, De Rocquigny H, Maigret B, Darlix JL, Roques BP. Determination of the structure of the nucleocapsid protein NCp7 from the human immunodeficiency virus type 1 by 1H NMR. EMBO J 1992; 11:3059 - 3065
   PubMed Web of Science ®Google Scholar
• Lam WC, Maki AH, Casas-Finet JR, Erickson JW, Kane BP, Sowder RC 2nd, et al. Phosphorescence and optically detected magnetic resonance investigation of the binding of the nucleocapsid protein of the human immunodeficiency virus type 1 and related peptides to RNA. Biochemistry 1994; 33:10693 - 10700
   PubMed Web of Science ®Google Scholar
• Morellet N, Demene H, Teilleux V, Huynh-Dinh T, de Rocquigny H, Fournie-Zaluski MC, et al. Structure of the complex between the HIV-1 nucleocapsid protein NCp7 and the single-stranded pentanucleotide d(ACG CC). J Mol Biol 1998; 283:419 - 434
   PubMed Web of Science ®Google Scholar
• Urbaneja MA, Kane BP, Johnson DG, Gorelick RJ, Henderson LE, Casas-Finet JR. Binding properties of the human immunodeficiency virus type 1 nucleocapsid protein p7 to a model RNA: elucidation of the structural determinants for function. J Mol Biol 1999; 287:59 - 75
   PubMed Web of Science ®Google Scholar
• Kafaie J, Dolatshahi M, Ajamian L, Song R, Mouland AJ, Rouiller I, et al. Role of capsid sequence and immature nucleocapsid proteins p9 and p15 in Human Immunodeficiency Virus type 1 genomic RNA dimerization. Virology 2009; 385:233 - 244
   PubMed Web of Science ®Google Scholar
• Kafaie J, Song R, Abrahamyan L, Mouland AJ, Laughrea M. Mapping of nucleocapsid residues important for HIV-1 genomic RNA dimerization and packaging. Virology 2008; 375:592 - 610
   Google Scholar
• Feng YX, Campbell S, Harvin D, Ehresmann B, Ehresmann C, Rein A. The human immunodeficiency virus type 1 Gag polyprotein has nucleic acid chaperone activity: possible role in dimerization of genomic RNA and placement of tRNA on the primer binding site. J Virol 1999; 73:4251 - 4256
   PubMed Web of Science ®Google Scholar
• Feng YX, Fu W, Winter AJ, Levin JG, Rein A. Multiple regions of Harvey sarcoma virus RNA can dimerize in vitro. J Virol 1995; 69:2486 - 2490
   PubMed Web of Science ®Google Scholar
• Darugar Q, Kim H, Gorelick RJ, Landes C. Human T-cell lymphotropic virus type 1 nucleocapsid protein-induced structural changes in transactivation response DNA hairpin measured by single-molecule fluorescence resonance energy transfer. J Virol 2008; 82:12164 - 12171
   PubMed Web of Science ®Google Scholar
• Beltz H, Azoulay J, Bernacchi S, Clamme JP, Ficheux D, Roques B, et al. Impact of the terminal bulges of HIV-1 cTAR DNA on its stability and the destabilizing activity of the nucleocapsid protein NCp7. J Mol Biol 2003; 328:95 - 108
   PubMed Web of Science ®Google Scholar
• Qualley DF, Stewart-Maynard KM, Wang F, Mitra M, Gorelick RJ, Rouzina I, et al. C-terminal domain modulates the nucleic acid chaperone activity of human T-cell leukemia virus type 1 nucleocapsid protein via an electrostatic mechanism. J Biol Chem 2010; 285:295 - 307
   PubMed Web of Science ®Google Scholar
• Linial ML. Foamy viruses are unconventional retroviruses. J Virol 1999; 73:1747 - 1755
   PubMed Web of Science ®Google Scholar
• Yu SF, Edelmann K, Strong RK, Moebes A, Rethwilm A, Linial ML. The carboxyl terminus of the human foamy virus Gag protein contains separable nucleic acid binding and nuclear transport domains. J Virol 1996; 70:8255 - 8262
   PubMed Web of Science ®Google Scholar
• Stenbak CR, Linial ML. Role of the C terminus of foamy virus Gag in RNA packaging and Pol expression. J Virol 2004; 78:9423 - 9430
   PubMed Web of Science ®Google Scholar
• Zamborlini A, Renault N, Saib A, Delelis O. Early reverse transcription is essential for productive foamy virus infection. PLoS One 2010; 5:11023
   Web of Science ®Google Scholar
• Yu SF, Sullivan MD, Linial ML. Evidence that the human foamy virus genome is DNA. J Virol 1999; 73:1565 - 1572
   PubMed Web of Science ®Google Scholar
• Lehmann-Che J, Giron ML, Delelis O, Lochelt M, Bittoun P, Tobaly-Tapiero J, et al. Protease-dependent uncoating of a complex retrovirus. J Virol 2005; 79:9244 - 9253
   PubMed Web of Science ®Google Scholar
• Ganser-Pornillos BK, Yeager M, Sundquist WI. The structural biology of HIV assembly. Curr Opin Struct Biol 2008; 18:203 - 217
   PubMed Web of Science ®Google Scholar
• Khan R, Giedroc DP. Nucleic acid binding properties of recombinant Zn2 HIV-1 nucleocapsid protein are modulated by COOH-terminal processing. J Biol Chem 1994; 269:22538 - 22546
   PubMed Web of Science ®Google Scholar
• Mirambeau G, Lyonnais S, Coulaud D, Hameau L, Lafosse S, Jeusset J, et al. Transmission electron microscopy reveals an optimal HIV-1 nucleocapsid aggregation with single-stranded nucleic acids and the mature HIV-1 nucleocapsid protein. J Mol Biol 2006; 364:496 - 511
   PubMed Web of Science ®Google Scholar
• Rajkowitsch L, Chen D, Stampfl S, Semrad K, Waldsich C, Mayer O, et al. RNA chaperones, RNA annealers and RNA helicases. RNA Biol 2007; 4:118 - 130
   PubMed Web of Science ®Google Scholar
• Chen J, Nikolaitchik O, Singh J, Wright A, Bencsics CE, Coffin JM, et al. High efficiency of HIV-1 genomic RNA packaging and heterozygote formation revealed by single virion analysis. Proc Natl Acad Sci USA 2009; 106:13535 - 13540
   PubMed Web of Science ®Google Scholar
• Fu W, Dang Q, Nagashima K, Freed EO, Pathak VK, Hu WS. Effects of Gag mutation and processing on retroviral dimeric RNA maturation. J Virol 2006; 80:1242 - 1249
   PubMed Web of Science ®Google Scholar
• Hargittai MR, Gorelick RJ, Rouzina I, Musier-Forsyth K. Mechanistic insights into the kinetics of HIV-1 nucleocapsid protein-facilitated tRNA annealing to the primer binding site. J Mol Biol 2004; 337:951 - 968
   PubMed Web of Science ®Google Scholar
• D'Souza V, Summers MF. Structural basis for packaging the dimeric genome of Moloney murine leukaemia virus. Nature 2004; 431:586 - 590
   PubMed Web of Science ®Google Scholar
• Dey A, York D, Smalls-Mantey A, Summers MF. Composition and sequence-dependent binding of RNA to the nucleocapsid protein of Moloney murine leukemia virus. Biochemistry 2005; 44:3735 - 3744
   PubMed Web of Science ®Google Scholar
• Gherghe C, Lombo T, Leonard CW, Datta SAK, Bess JW, Gorelick RJ, et al. Definition of a high-affinity Gag recognition structure mediating packaging of a retroviral RNA genome. Proc Natl Acad Sci USA 2010; 107:19248 - 19253
   PubMed Web of Science ®Google Scholar
• Tanchou V, Gabus C, Rogemond V, Darlix JL. Formation of stable and functional HIV-1 nucleoprotein complexes in vitro. J Mol Biol 1995; 252:563 - 571
   PubMed Web of Science ®Google Scholar
• Muriaux D, Mirro J, Harvin D, Rein A. RNA is a structural element in retrovirus particles. Proc Natl Acad Sci USA 2001; 98:5246 - 5251
   PubMed Web of Science ®Google Scholar
• Anderson EC, Lever AM. Human immunodeficiency virus type 1 Gag polyprotein modulates its own translation. J Virol 2006; 80:10478 - 10486
   Google Scholar
• Ott DE, Coren LV, Gagliardi TD. Redundant roles for nucleocapsid and matrix RNA-binding sequences in human immunodeficiency virus type 1 assembly. J Virol 2005; 79:13839 - 13847
   PubMed Web of Science ®Google Scholar
• Burniston MT, Cimarelli A, Colgan J, Curtis SP, Luban J. Human immunodeficiency virus type 1 Gag polyprotein multimerization requires the nucleocapsid domain and RNA and is promoted by the capsid-dimer interface and the basic region of matrix protein. J Virol 1999; 73:8527 - 8540
   PubMed Web of Science ®Google Scholar
• Purohit P, Dupont S, Stevenson M, Green MR. Sequence-specific interaction between HIV-1 matrix protein and viral genomic RNA revealed by in vitro genetic selection. RNA 2001; 7:576 - 584
   PubMed Web of Science ®Google Scholar
• Wang H, Norris KM, Mansky LM. Involvement of the matrix and nucleocapsid domains of the bovine leukemia virus Gag polyprotein precursor in viral RNA packaging. J Virol 2003; 77:9431 - 9438
   PubMed Web of Science ®Google Scholar
• Lee EG, Linial ML. Basic residues of the retroviral nucleocapsid play different roles in Gag-Gag and Gag-Psi RNA interactions. J Virol 2004; 78:8486 - 8495
   Google Scholar
• Wu T, Datta SA, Mitra M, Gorelick RJ, Rein A, Levin JG. Fundamental differences between the nucleic acid chaperone activities of HIV-1 nucleocapsid protein and Gag or Gag-derived proteins: Biological implications. Virology 2010; 405:556 - 567
   PubMed Web of Science ®Google Scholar
• Guo J, Wu T, Kane BF, Johnson DG, Henderson LE, Gorelick RJ, et al. Subtle alterations of the native zinc finger structures have dramatic effects on the nucleic acid chaperone activity of human immunodeficiency virus type 1 nucleocapsid protein. J Virol 2002; 76:4370 - 4378
   PubMed Web of Science ®Google Scholar
• Briggs JA, Wilk T, Welker R, Krausslich HG, Fuller SD. Structural organization of authentic, mature HIV-1 virions and cores. EMBO J 2003; 22:1707 - 1715
   PubMed Web of Science ®Google Scholar
• Cruceanu M, Gorelick RJ, Musier-Forsyth K, Rouzina I, Williams MC. Rapid kinetics of protein-nucleic acid interaction is a major component of HIV-1 nucleocapsid protein's nucleic acid chaperone function. J Mol Biol 2006; 363:867 - 877
   PubMed Web of Science ®Google Scholar
• Mirambeau G, Lyonnais S, Coulaud D, Hameau L, Lafosse S, Jeusset J, et al. HIV-1 protease and reverse transcriptase control the architecture of their nucleocapsid partner. PLoS One 2007; 2:669
   Web of Science ®Google Scholar
• Pettit SC, Sheng N, Tritch R, Erickson-Viitanen S, Swanstrom R. The regulation of sequential processing of HIV-1 Gag by the viral protease. Adv Exp Med Biol 1998; 436:15 - 25
   PubMed Web of Science ®Google Scholar
• Sheng N, Pettit SC, Tritch RJ, Ozturk DH, Rayner MM, Swanstrom R, et al. Determinants of the human immunodeficiency virus type 1 p15NC-RNA interaction that affect enhanced cleavage by the viral protease. J Virol 1997; 71:5723 - 5732
   PubMed Web of Science ®Google Scholar
• Fisher RJ, Rein A, Fivash M, Urbaneja MA, Casas-Finet JR, Medaglia M, et al. Sequence-specific binding of human immunodeficiency virus type 1 nucleocapsid protein to short oligonucleotides. J Virol 1998; 72:1902 - 1909
   PubMed Web of Science ®Google Scholar
• Williams MC, Rouzina I, Wenner JR, Gorelick RJ, Musier-Forsyth K, Bloomfield VA. Mechanism for nucleic acid chaperone activity of HIV-1 nucleocapsid protein revealed by single molecule stretching. Proc Natl Acad Sci USA 2001; 98:6121 - 6126
   PubMed Web of Science ®Google Scholar
• Grohmann D, Godet J, Mely Y, Darlix JL, Restle T. HIV-1 nucleocapsid traps reverse transcriptase on nucleic acid substrates. Biochemistry 2008; 47:12230 - 12240
   PubMed Web of Science ®Google Scholar
• Lener D, Tanchou V, Roques BP, Le Grice SF, Darlix JL. Involvement of HIV-I nucleocapsid protein in the recruitment of reverse transcriptase into nucleoprotein complexes formed in vitro. J Biol Chem 1998; 273:33781 - 33786
   PubMed Web of Science ®Google Scholar
• Coren LV, Thomas JA, Chertova E, Sowder RC 2nd, Gagliardi TD, Gorelick RJ, et al. Mutational analysis of the C-terminal Gag cleavage sites in human immunodeficiency virus type 1. J Virol 2007; 81:10047 - 10054
   PubMed Web of Science ®Google Scholar
• Kolli M, Stawiski E, Chappey C, Schiffer CA. Human immunodeficiency virus type 1 protease-correlated cleavage site mutations enhance inhibitor resistance. J Virol 2009; 83:11027 - 11042
   PubMed Web of Science ®Google Scholar
• Hsu M, Wainberg MA. Interactions between human immunodeficiency virus type 1 reverse transcriptase, tRNA primer and nucleocapsid protein during reverse transcription. J Hum Virol 2000; 3:16 - 26
   PubMedGoogle Scholar
• Muller B, Anders M, Akiyama H, Welsch S, Glass B, Nikovics K, et al. HIV-1 Gag processing intermediates trans-dominantly interfere with HIV-1 infectivity. J Biol Chem 2009; 284:29692 - 29703
   PubMed Web of Science ®Google Scholar
• Iwatani Y, Chan DS, Wang F, Maynard KS, Sugiura W, Gronenborn AM, et al. Deaminase-independent inhibition of HIV-1 reverse transcription by APOBEC3G. Nucleic Acids Res 2007; 35:7096 - 7108
   PubMed Web of Science ®Google Scholar
• Fassati A, Goff SP. Characterization of intracellular reverse transcription complexes of human immunodeficiency virus type 1. J Virol 2001; 75:3626 - 3635
   Google Scholar
• Nermut MV, Fassati A. Structural analyses of purified human immunodeficiency virus type 1 intracellular reverse transcription complexes. J Virol 2003; 77:8196 - 8206
   PubMed Web of Science ®Google Scholar
• Iordanskiy S, Berro R, Altieri M, Kashanchi F, Bukrinsky M. Intracytoplasmic maturation of the human immunodeficiency virus type 1 reverse transcription complexes determines their capacity to integrate into chromatin. Retrovirology 2006; 3:4
   PubMed Web of Science ®Google Scholar
• Dismuke DJ, Aiken C. Evidence for a functional link between uncoating of the human immunodeficiency virus type 1 core and nuclear import of the viral preintegration complex. J Virol 2006; 80:3712 - 3720
   Google Scholar
• Anthony RM, Destefano JJ. In vitro synthesis of long DNA products in reactions with HIV-RT and nucleocapsid protein. J Mol Biol 2007; 365:310 - 324
   PubMed Web of Science ®Google Scholar
• Wisniewski M, Balakrishnan M, Palaniappan C, Fay PJ, Bambara RA. Unique progressive cleavage mechanism of HIV reverse transcriptase RNase H. Proc Natl Acad Sci USA 2000; 97:11978 - 11983
   PubMed Web of Science ®Google Scholar
• Schultz SJ, Zhang M, Champoux JJ. Sequence, distance and accessibility are determinants of 5′-end-directed cleavages by retroviral RNases H. J Biol Chem 2006; 281:1943 - 1955
   PubMed Web of Science ®Google Scholar
• Kotova S, Li M, Dimitriadis EK, Craigie R. Nucleoprotein intermediates in HIV-1 DNA integration visualized by atomic force microscopy. J Mol Biol 2010; 399:491 - 500
   PubMed Web of Science ®Google Scholar
• Houzet L, Morichaud Z, Didierlaurent L, Muriaux D, Darlix JL, Mougel M. Nucleocapsid mutations turn HIV-1 into a DNA-containing virus. Nucl Acids Res 2008; 36:2311 - 2319
   PubMed Web of Science ®Google Scholar
• Thomas JA, Gagliardi TD, Alvord WG, Lubomirski M, Bosche WJ, Gorelick RJ. Human immunodeficiency virus type 1 nucleocapsid zinc-finger mutations cause defects in reverse transcription and integration. Virology 2006; 353:41 - 51
   PubMed Web of Science ®Google Scholar
• Thomas JA, Bosche WJ, Shatzer TL, Johnson DG, Gorelick RJ. Mutations in human immunodeficiency virus type 1 nucleocapsid protein zinc fingers cause premature reverse transcription. J Virol 2008; 82:9318 - 9328
   Google Scholar
• Wilk T, Gowen B, Fuller SD. Actin associates with the nucleocapsid domain of the human immunodeficiency virus Gag polyprotein. J Virol 1999; 73:1931 - 1940
   PubMedGoogle Scholar
• Liu B, Dai R, Tian CJ, Dawson L, Gorelick R, Yu XF. Interaction of the human immunodeficiency virus type 1 nucleocapsid with actin. J Virol 1999; 73:2901 - 2908
   PubMed Web of Science ®Google Scholar
• Krogstad P, Geng YZ, Rey O, Canon J, Ibarrondo FJ, Ackerson B, et al. Human immunodeficiency virus nucleocapsid protein polymorphisms modulate the infectivity of RNA packaging mutants. Virology 2002; 294:282 - 288
   PubMed Web of Science ®Google Scholar
• Gladnikoff M, Shimoni E, Gov NS, Rousso I. Retroviral assembly and budding occur through an actin-driven mechanism. Biophys J 2009; 97:2419 - 2428
   PubMed Web of Science ®Google Scholar
• Chen C, Jin J, Rubin M, Huang L, Sturgeon T, Weixel KM, et al. Association of Gag multimers with filamentous actin during equine infectious anemia virus assembly. Curr HIV Res 2007; 5:315 - 323
   PubMed Web of Science ®Google Scholar
• Zennou V, Perez-Caballero D, Gottlinger H, Bieniasz PD. APOBEC3G incorporation into human immunodeficiency virus type 1 particles. J Virol 2004; 78:12058 - 12061
   PubMed Web of Science ®Google Scholar
• Luo K, Liu B, Xiao Z, Yu Y, Yu X, Gorelick R, et al. Amino-terminal region of the human immunodeficiency virus type 1 nucleocapsid is required for human APOBEC3G packaging. J Virol 2004; 78:11841 - 11852
   PubMed Web of Science ®Google Scholar
• Burnett A, Spearman P. APOBEC3G multimers are recruited to the plasma membrane for packaging into human immunodeficiency virus type 1 virus-like particles in an RNA-dependent process requiring the NC basic linker. J Virol 2007; 81:5000 - 5013
   PubMed Web of Science ®Google Scholar
• Huthoff H, Towers GJ. Restriction of retroviral replication by APOBEC3G/F and TRIM5alpha. Trends Microbiol 2008; 16:612 - 619
   PubMed Web of Science ®Google Scholar
• Guo F, Cen S, Niu M, Yang Y, Gorelick RJ, Kleiman L. The interaction of APOBEC3G with human immunodeficiency virus type 1 nucleocapsid inhibits tRNALys3 annealing to viral RNA. J Virol 2007; 81:11322 - 11331
   PubMed Web of Science ®Google Scholar
• Bishop KN, Verma M, Kim EY, Wolinsky SM, Malim MH. APOBEC3G Inhibits Elongation of HIV-1 Reverse Transcripts. PLoS Pathogens 2008; 4:1000231
   Web of Science ®Google Scholar
• Popov S, Popova E, Inoue M, Gottlinger HG. Human immunodeficiency virus type 1 Gag engages the Bro1 domain of ALIX/AIP1 through the nucleocapsid. J Virol 2008; 82:1389 - 1398
   PubMed Web of Science ®Google Scholar
• Popov S, Popova E, Inoue M, Gottlinger HG. Divergent Bro1 domains share the capacity to bind human immunodeficiency virus type 1 nucleocapsid and to enhance virus-like particle production. J Virol 2009; 83:7185 - 7193
   PubMed Web of Science ®Google Scholar
• Henriet S, Sinck L, Bec G, Gorelick RJ, Marquet R, Paillart JC. Vif is a RNA chaperone that could temporally regulate RNA dimerization and the early steps of HIV-1 reverse transcription. Nucleic Acids Res 2007; 35:5141 - 5153
   Google Scholar
• Boudier C, Storchak R, Sharma KK, Didier P, Follenius-Wund A, Muller S, et al. The mechanism of HIV-1 Tat-directed nucleic acid annealing supports its role in reverse transcription. J Mol Biol 2010; 400:487 - 501
   PubMed Web of Science ®Google Scholar
• Romani B, Engelbrecht S, Glashoff RH. Functions of Tat: the versatile protein of human immunodeficiency virus type 1. J Gen Virol 2010; 91:1 - 12
   PubMed Web of Science ®Google Scholar
• Malim MH, Emerman M. HIV-1 accessory proteins—ensuring viral survival in a hostile environment. Cell Host Microbe 2008; 3:388 - 398
   PubMed Web of Science ®Google Scholar
• Zhang H, Pomerantz RJ, Dornadula G, Sun Y. Human immunodeficiency virus type 1 Vif protein is an integral component of an mRNP complex of viral RNA and could be involved in the viral RNA folding and packaging process. J Virol 2000; 74:8252 - 8261
   PubMed Web of Science ®Google Scholar
• Bardy M, Gay B, Pebernard S, Chazal N, Courcoul M, Vigne R, et al. Interaction of human immunodeficiency virus type 1 Vif with Gag and Gag-Pol precursors: co-encapsidation and interference with viral protease-mediated Gag processing. J Gen Virol 2001; 82:2719 - 2733
   PubMed Web of Science ®Google Scholar
• Huvent I, Hong SS, Fournier C, Gay B, Tournier J, Carriere C, et al. Interaction and co-encapsidation of human immunodeficiency virus type 1 Gag and Vif recombinant proteins. J Gen Virol 1998; 79:1069 - 1081
   Google Scholar
• Syed F, McCrae MA. Interactions in vivo between the Vif protein of HIV-1 and the precursor (Pr55(GAG)) of the virion nucleocapsid proteins. Arch Virol 2009; 154:1797 - 1805
   PubMed Web of Science ®Google Scholar
• Akari H, Fujita M, Kao S, Khan MA, Shehu-Xhilaga M, Adachi A, et al. High level expression of human immunodeficiency virus type-1 Vif inhibits viral infectivity by modulating proteolytic processing of the Gag precursor at the p2/nucleocapsid processing site. J Biol Chem 2004; 279:12355 - 12362
   PubMed Web of Science ®Google Scholar
• Kataropoulou A, Bovolenta C, Belfiore A, Trabatti S, Garbelli A, Porcellini S, et al. Mutational analysis of the HIV-1 auxiliary protein Vif identifies independent domains important for the physical and functional interaction with HIV-1 reverse transcriptase. Nucleic Acids Res 2009; 37:3660 - 3669
   Google Scholar
• Henriet S, Richer D, Bernacchi S, Decroly E, Vigne R, Ehresmann B, et al. Cooperative and specific binding of Vif to the 5′ region of HIV-1 genomic RNA. J Mol Biol 2005; 354:55 - 72
   Google Scholar
• Sova P, Volsky DJ, Wang L, Chao W. Vif is largely absent from human immunodeficiency virus type 1 mature virions and associates mainly with viral particles containing unprocessed Gag. J Virol 2001; 75:5504 - 5517
   PubMed Web of Science ®Google Scholar
• Mazze FM, Degreve L. The role of viral and cellular proteins in the budding of human immunodeficiency virus. Acta Virol 2006; 50:75 - 85
   PubMed Web of Science ®Google Scholar
• Yu XF, Dawson L, Tian CJ, Flexner C, Dettenhofer M. Mutations of the human immunodeficiency virus type 1 p6Gag domain result in reduced retention of Pol proteins during virus assembly. J Virol 1998; 72:3412 - 3417
   PubMed Web of Science ®Google Scholar
• Fritz JV, Dujardin D, Godet J, Didier P, De Mey J, Darlix JL, et al. HIV-1 Vpr oligomerization but not that of Gag directs the interaction between Vpr and Gag. J Virol 2010; 84:1585 - 1596
   PubMed Web of Science ®Google Scholar
• de Rocquigny H, Petitjean P, Tanchou V, Decimo D, Drouot L, Delaunay T, et al. The zinc fingers of HIV nucleocapsid protein NCp7 direct interactions with the viral regulatory protein Vpr. J Biol Chem 1997; 272:30753 - 30759
   PubMed Web of Science ®Google Scholar
• Zhou J, Bean RL, Vogt VM, Summers M. Solution structure of the Rous sarcoma virus nucleocapsid protein: muPsi RNA packaging signal complex. J Mol Biol 2007; 365:453 - 467
   PubMed Web of Science ®Google Scholar
• Yoshinaka Y, Luftig RB. Cleavage of Rauscher leukaemia virus (R-MuLV) Pr65Gag by the Moloney leukaemia virus (M-MuLV) proteolytic activity produces the R-MuLV-specific but not the M-MuLV-specific 40,000 dalton intermediate polypeptide. J Gen Virol 1981; 54:33 - 38
   PubMed Web of Science ®Google Scholar